Dudediligence.

Whitehawk Therapeutics, Inc

WHWKNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$7.2MSep ’24$7.2MDec ’24$7.1MMar ’25$0.00Jun ’25$0.00Sep ’25$0.00Dec ’25$0.00Mar ’26$0.00Jun ’26
Net income, by quarter
−$12.5MSep ’24−$18.3MDec ’24$73.0MMar ’25−$52.6MJun ’25−$17.7MSep ’25−$23.3MDec ’25−$22.2MMar ’26−$16.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$14.0M$15.2M$24.4M$26.0M$7.1M
Gross profit$14.0M$13.9M$21.5M$23.0M$6.4M
Operating income−$111.2M−$62.7M−$71.9M−$67.5M−$114.4M
Net income−$110.1M−$60.5M−$65.8M−$63.7M−$20.6M
Operating cash flow−$22.4M−$49.6M−$59.7M−$59.5M−$97.4M
Free cash flow−$22.5M−$50.1M−$63.6M−$61.2M−$98.0M
Cash$149.0M$39.0M$62.9M$28.7M$37.6M
Shares outstanding20.9M24.4M24.6M24.7M47.1M